Search Results - "Zannad F"

Managing hypertension: a question of STRATHE.

Authors: Zannad, F.¹ f.zannad@chu-nancy.fr

Source: Journal of Human Hypertension. Jun2005 Supplement, Vol. 19, pS3-S7. 5p.

ENVIRONMENTAL AND GENETIC DETERMINANTS OF INTIMA–MEDIA THICKNESS OF THE CAROTID ARTERY.

Authors: Zannad, F Sass, C Visvikis, S

Source: Clinical & Experimental Pharmacology & Physiology. Dec2001, Vol. 28 Issue 12, p1007-1010. 4p. 3 Charts.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Eplerenone and Atrial Fibrillation in Mild Systolic Heart Failure: Results From the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) Study.

Authors: Swedberg K Zannad F McMurray JJ et al.

Source: Journal of the American College of Cardiology (JACC). May2012, Vol. 59 Issue 18, p1598-1603. 6p.

Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF)

Authors: Zannad F McMurray JJ Drexler H et al.

Source: European Journal of Heart Failure. Jun2010, Vol. 12 Issue 6, p617-622. 6p.

Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program.

Authors: Blair JE Zannad F Konstam MA et al.

Source: Journal of the American College of Cardiology (JACC). Nov2008, Vol. 52 Issue 20, p1640-1648. 9p.

Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension.

Authors: Rajagopalan S Zannad F Radauceanu A et al.

Source: American Journal of Cardiology. Jul2007, Vol. 100 Issue 2, p222-226. 5p.

Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies.

Authors: Zannad, F Kessler, M Lehert, P et al.

Source: Kidney International. Oct2006, Vol. 70 Issue 7, p1318-1324. 7p. 5 Charts, 1 Graph.

The effect of spironolactone on morbidity and mortality in patients with severe heart failure.

Authors: Pitt B Zannad F Remme WJ et al.

Source: New England Journal of Medicine. 09/02/99, Vol. 341 Issue 10, p709-717. 9p.

Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL.

Authors: Rossignol P Cridlig J Lehert P et al.

Source: Hypertension (0194911X). Aug2012, Vol. 60 Issue 2, p339-346.

Early effects of eplerenone on neurohormones after acute myocardial infarction

Authors: Ketelslegers, J.-M. Zannad, F. Gruson, D. et al.

Source: European Journal of Heart Failure. Supplements. Jun2008, Vol. 7 Issue 1, p203-203. 1p.

Regression analysis of mortality data from the EPHESUS trial reveals significantly higher risk of death for patients with non-ST segment elevation myocardial infarction

Authors: Zannad, F. Pitt, B. Filippatos, G. et al.

Source: European Journal of Heart Failure. Supplements. Jun2008, Vol. 7 Issue 1, p104-104. 1p.

Stratification of mortality by risk scores from the EPHESUS trial reveals significant interaction between left ventricular ejection fraction and Killip class

Authors: Pitt, B. Zannad, F. Van Veldhuisen, D.J. et al.

Source: European Journal of Heart Failure. Supplements. Jun2008, Vol. 7 Issue 1, p72-72. 1p.

Regional differences in baseline characteristics and outcomes in patients admitted with acute heart failure - results from the EVEREST program

Authors: Blair, J. Zannad, F. Konstam, M. et al.

Source: European Journal of Heart Failure. Supplements. Jun2008, Vol. 7 Issue 1, p2-2. 1p.

Retinoic acid and lipopolysaccharide act synergistically to increase prostanoid concentrations in rats in vivo.

Authors: Devaux, Yvan Seguin, Carole Grosjean, Sandrine et al.

Source: Journal of Nutrition. Oct2001, Vol. 131 Issue 10, p2628-2635.

Antihypertensive Effects and Tolerability of Candesartan Cilexetil Alone and in Combination with Amlodipine.

Authors: Farsang, C. Kawecka-Jaszcz, K. Langan, J. et al.

Source: Clinical Drug Investigation. 2001, Vol. 21 Issue 1, p17.

Limitation of the excessive extracellular matrix turnover is a major determinant of the beneficial effect of spironolactone on survival in patients with CHF: Insights from the RALES trial.

Authors: Zannad, F. Alla, F. Dousset, B. et al.

Source: European Journal of Heart Failure. Jun2000, Vol. 2 Issue S1, p98-98. 1p.

Determinants and prognostic value of serum markers of cardiac fibrosis in heart failure: Results from the RALES database.

Authors: Zannad, F. Alla, F. Dousset, B.

Source: European Journal of Heart Failure. Jun2000, Vol. 2 Issue S1, p104-104. 1p.

Physical activity, skeletal muscle beta-adrenoceptor changes and oxidative metabolism in experimental chronic heart failure.

Authors: Michel, C. Chati, Z. Mertes, P.M. et al.

Source: Fundamental & Clinical Pharmacology. 1998: Vol. 12 Issue 3. p. 263-269-269.